Every article, newest first.
In a study of seventy-four colorectal cancer survivors published Oct. 27, 2026, in Psychoneuroendocrinology, people whose cortisol rose and fell more sharply across the day reported less fatigue over the 12 months…
A study of 185 patients and 15 genetic counselors, published Oct. 1, 2026, in JAMA Network Open, found that counselors' explicit medical stereotypes favoring White patients were linked to poorer alliance, satisfaction…
An analysis of 580 people with lymphoma treated with the CAR-T therapy axi-cel, published Oct. 23, 2026, in Nature Medicine, found that products with more naive-like T cells were linked to longer…
A study of cancer registries in California and Massachusetts, published Oct. 1, 2026, in JAMA Network Open, found that formerly incarcerated people had worse cancer survival (hazard ratio 1.71) than people never…
A study published Oct. 28, 2026, in Science Translational Medicine, combining a phase 2 trial of 106 patients with tumor data from 152 patients, found that B cells and antibody responses were…
An ASCO living guideline published Oct. 27, 2026, in the Journal of Clinical Oncology says everyone with newly diagnosed advanced ovarian cancer should get genetic testing, and that PARP inhibitor maintenance should…
In a phase 3 trial in China published Oct. 24, 2026, in NEJM, 58.5% of women with HER2-positive advanced breast cancer on anbenitamab plus a docetaxel formulation were free of progression at…
A Cochrane review published Oct. 27, 2026, found that ALPPS, a staged liver surgery, probably increases how many people with colorectal liver metastases get their tumors removed, with little to no difference…
In a first-in-human trial in 79 healthy adults, the oral drug VES001 was well tolerated and raised levels of progranulin, a protein that is too low in one genetic form of frontotemporal…
A systematic review of 42 studies, published in October 2026 in Alzheimer's & Dementia, found that social isolation and loneliness are linked to partly different brain regions, and both to more white…
In the HIMALAYA trial of 305 people with ALS in 13 countries, the RIPK1 inhibitor SAR443820 did not slow functional decline over 24 weeks and caused more liver enzyme increases than placebo.
A study of 302 dementia-free older adults in Southeast Asia, published in October 2026 in Alzheimer's & Dementia, found that narrower small arteries in the retina were linked to a higher chance…
In a study of ninety-three women aged 35-63, published Oct. 27, 2026, in Medicine & Science in Sports & Exercise, those who exercised regularly showed less age-related slowing in reaction time and…
A review of fourteen studies in adults aged 60 or older found that probiotics, prebiotics and synbiotics improved global cognition scores by 1.28 points in a pooled subgroup, though the studies were…
In a randomized trial of 86 family caregivers of people with dementia, a mobile app designed with caregivers' input improved their overall and psychological quality of life at 8 weeks, but did…
In a randomized trial published Oct. 28, 2026, in JAMA Psychiatry, a mindfulness program for opioid use disorder shifted brain activity away from drug cues toward natural rewards, reduced craving and extended…
In a phase 2b trial published Oct. 26, 2026, in JAMA, one intranasal dose of mebufotenin cut depression scores more than a very low dose at day 29 in adults with treatment-resistant…
A meta-analysis of sixteen randomized trials with 1992 participants found that psychodynamic psychotherapy lasting at least nine months reduced depressive symptoms compared with other conditions, with effects generally sustained.
In 486 intensive care patients with traumatic brain injury and anemia, transfusing at a higher hemoglobin threshold was linked to fewer poor neurological outcomes at 180 days than a restrictive strategy, though…
A real-world study of 181 people with Alzheimer's in China, published in October 2026 in Alzheimer's & Dementia, found that responses to lecanemab emerged at 6 months, mostly in early disease, and…
